Skip to main content
Caplight Logo









Tucuvi

Tucuvi

Private
MadridHealthcare & Life Scienceshttps://www.tucuvi.com/

Last Round

Series A

Jan 8, 2026

Total Funding Raised

$29.23M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Tucuvi is a healthcare technology company that provides a clinical voice AI platform designed to automate care management for healthcare organizations.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, NLP & Conversational AI, Patient Engagement, Medical Devices, Telemedicine

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

remote patient monitoringRPMvoice AIclinical AIpatient engagementconversational AIsoftware as a medical deviceSaMDAI health assistantvirtual careworkflow automationchronic disease managementtelemedicineAI scribehealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tucuvi Comparables

Compare Tucuvi with similar companies based on industry and business-model similarity.

Tucuvi comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Orbita
78%
Hippocratic AI
76%
Hyro
76%

Tucuvi Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 8, 2026
GrantOct 15, 2022
GrantMar 17, 2022
SeedMay 24, 2021
Pre SeedApr 29, 2020

Key People

Founding team and executive leadership

María González Manso

Founder And CEO Of Tucuvi - Augmenting Care Teams Capacity With Clinical Conversational AI

Founding Team

Fernando Dal Re Olleros

COO

Executive Team

Tucuvi Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors increased 81% MoM.

  • Aug 2, 2026

    Grew 26% QoQ, from 61 to 77 employees.

Recent news

Latest coverage and updates

  • receives_financingSep 24, 2026

    Tucuvi receives $5.61M in financing from AXIS, the ICO's venture capital firm, through Fond-ICO Crecimiento to support growth and international expansion.

Tucuvi Filings

Explore SEC and related filing metadata, where available.

Tucuvi filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tucuvi's valuation, stock price, and market status.

Is Tucuvi a public or private company?

Tucuvi is a private company.

What is the current stock price of Tucuvi?

Tucuvi is a private company, so its shares have no public market price. Caplight tracks Tucuvi's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Tucuvi worth (valuation)?

Valuation information for Tucuvi is not publicly available.

Can I buy Tucuvi stock?

Tucuvi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Tucuvi's last funding round?

Tucuvi's most recent funding round was Series A on January 8, 2026.

Who are the main investors in Tucuvi?

Key investors in Tucuvi include Cathay Capital, Afi Inversiones Globales, SGIIC, Leadwind, Kfund, K Fund.

Will Tucuvi IPO soon?

No public IPO plans have been announced for Tucuvi.

How can I track Tucuvi secondary market activity?

Caplight tracks bids, offers, and trades in Tucuvi's shares on secondary markets.

Firmographic Details

HeadquartersMadrid
Employee Range58
Year Founded2019
Last FundingJan 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?